ER stress modulates the immune regulatory ability in gut M2 cells of patients with ulcerative colitis

Baisui Feng1, Lingzhi Xu2, Shuo Song3,4

  • 1Department of Gastroenterology, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Iscience
|April 24, 2023
PubMed

Insights

In ulcerative colitis (UC), M2 macrophages show impaired immune suppression due to endoplasmic reticulum stress. Ring-finger protein 20 (Rnf20) reduces immune function, but its inhibition restores macrophage capacity.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Macrophages (Mφ) are key immune cells in the colon.
  • Ulcerative colitis (UC) involves dysregulated immune responses in the gut.
  • M2 macrophages play a role in immune regulation and tissue repair.

Purpose of the Study:

  • To characterize the immune regulatory function of Mφ from UC patient colon lavage fluid (CLF).
  • To investigate the role of endoplasmic reticulum (ER) stress in UC M2 macrophages.
  • To identify molecular mechanisms underlying impaired immune suppression in UC.

Main Methods:

  • Isolation and characterization of Mφ from UC patient CLF.
  • Analysis of M2 Mφ abundance and immune suppressive function.
  • Detection of ER stress markers and gene expression analysis (XBP1, PD-L1, Rnf20).
  • Functional assays involving Rnf20 inhibition and experimental colitis models.

Main Results:

  • Mφs constituted a significant portion of CLF cells (21.3%).
  • UC M2 Mφs exhibited reduced abundance and weaker immune suppressive function.
  • High ER stress markers and a negative correlation between spliced X box binding protein-1 (XBP1) and programmed death ligand-1 (PD-L1) were found in UC M2 Mφs.
  • XBP1 promoted Rnf20 expression, which decreased PD-L1 and impaired immune suppression.
  • Rnf20 inhibition restored M2 Mφ immune capacity and suppressed experimental colitis.

Conclusions:

  • ER stress impairs M2 Mφ immune regulatory function in UC.
  • The XBP1-Rnf20-PD-L1 axis is a key mechanism in UC-associated immune dysfunction.
  • Targeting Rnf20 may represent a therapeutic strategy for restoring immune homeostasis in UC.

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
337
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
480
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
243
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
601
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
186